These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 30238558)

  • 1. Initial modelling and updates on cost effectiveness from the first 10 years of a spleen registry.
    Luu S; Jones P; Woolley I; Spelman D; Gold L
    Aust N Z J Public Health; 2018 Oct; 42(5):463-466. PubMed ID: 30238558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of a post-splenectomy registry for prevention of sepsis in the asplenic.
    Woolley I; Jones P; Spelman D; Gold L
    Aust N Z J Public Health; 2006 Dec; 30(6):558-61. PubMed ID: 17209273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Registry for Patients With Asplenia/Hyposplenism Reduces the Risk of Infections With Encapsulated Organisms.
    Arnott A; Jones P; Franklin LJ; Spelman D; Leder K; Cheng AC
    Clin Infect Dis; 2018 Aug; 67(4):557-561. PubMed ID: 29471470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of optimizing use of statins in Australia: using outpatient data from the REACH Registry.
    Ademi Z; Reid CM; Hollingsworth B; Stoelwinder J; Steg PG; Bhatt DL; Vale M; Liew D;
    Clin Ther; 2011 Oct; 33(10):1456-65. PubMed ID: 21982384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding of the significance and health implications of asplenia in a cohort of patients with haemaglobinopathy: possible benefits of a spleen registry.
    Premawardena C; Bowden D; Kaplan Z; Dendle C; Woolley IJ
    Hematology; 2018 Sep; 23(8):526-530. PubMed ID: 29237357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharing.
    Wlodarczyk JH; Cleland LG; Keogh AM; McNeil KD; Perl K; Weintraub RG; Williams TJ
    Pharmacoeconomics; 2006; 24(9):903-15. PubMed ID: 16942124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a spleen registry on optimal post-splenectomy vaccination and care.
    Luu S; Dendle C; Jones P; Ojaimi S; Woolley IJ
    Hum Vaccin Immunother; 2018; 14(12):2894-2899. PubMed ID: 30020861
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis.
    Lee P; Brennan AL; Stub D; Dinh DT; Lefkovits J; Reid CM; Zomer E; Liew D
    BMJ Open; 2023 Apr; 13(4):e066106. PubMed ID: 37185178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of an extended nutritional intervention in older Australian hospitalized patients: a randomized controlled trial.
    Sharma Y; Thompson C; Miller M; Shahi R; Hakendorf P; Horwood C; Kaambwa B
    BMC Geriatr; 2018 Feb; 18(1):41. PubMed ID: 29402228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.
    Simpson KN; Luo MP; Chumney EC; King MS; Brun S
    Clin Drug Investig; 2007; 27(1):67-74. PubMed ID: 17177581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.
    Thurgar E; Barton S; Karner C; Edwards SJ
    Health Technol Assess; 2016 Mar; 20(24):v-vi, 1-486. PubMed ID: 27034016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the cost effectiveness of antidepressant treatment in primary care.
    Revicki DA; Brown RE; Palmer W; Bakish D; Rosser WW; Anton SF; Feeny D
    Pharmacoeconomics; 1995 Dec; 8(6):524-40. PubMed ID: 10160081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results.
    Pawęska J; Macioch T; Perkowski P; Budaj A; Niewada M
    Kardiol Pol; 2014; 72(9):823-30. PubMed ID: 24846362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium.
    Borisenko O; Lukyanov V; Debergh I; Dillemans B
    J Med Econ; 2018 Apr; 21(4):365-373. PubMed ID: 29271279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
    Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
    Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
    Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
    Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.